Health Catalyst, Inc. (HCAT)

Import this data to Google Sheets with:

=jivedata("HCAT","financials")

Full statements spill as a table. For one cell: =jivedata("HCAT","Revenue") or =jivedata("HCAT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Health Catalyst, Inc.

HCAT • CIK 0001636422

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-126,897	$-69,806	$-160,854	$-246,546
Interest Income (Expense), Nonoperating, Net	—	$637	$-16,404	$-17,122
Income (Loss) Attributable to Parent, before Tax	$-117,791	$-69,169	$-177,258	$-263,668
Income Tax Expense (Benefit)	$356	$333	$716	$1,149
Net Income (Loss) Attributable to Parent	$-118,147	$-69,502	$-177,974	$-264,817
Weighted Average Number of Shares Outstanding, Basic	56,418,397	60,184,920	69,896,134	74,084,647
Revenue from Contract with Customer, Excluding Assessed Tax	$295,938	$306,584	$311,136	$292,245
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$164,105	$165,805	$159,461	$144,723
Selling and Marketing Expense	$67,321	$54,387	$52,477	$45,478
Research and Development Expense	$72,627	$57,950	$49,770	$42,997
General and Administrative Expense	$76,559	$56,817	$49,559	$53,001
Depreciation, Depletion and Amortization, Nonproduction	$42,223	$41,431	$50,500	$48,590
Goodwill and Intangible Asset Impairment	—	—	$110,223	$110,223
Operating Expenses	$258,730	$210,585	$312,529	$394,068
Share-based Payment Arrangement, Expense	$55,756	$40,128	$27,012	$17,625

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$106,276	$249,645	$50,814	$60,589
Short-term Investments	$211,452	$142,355	$44,918	$42,850
Property, Plant and Equipment, Net	$25,712	$29,394	$33,838	$33,472
Accounts Receivable, after Allowance for Credit Loss, Current	$60,290	$57,182	$59,128	$41,901
Intangible Assets, Net (Excluding Goodwill)	$73,384	$86,052	$77,678	$56,121
Prepaid Expense and Other Assets, Current	$15,379	$16,468	$14,447	$11,627
Operating Lease, Right-of-Use Asset	$13,927	$12,058	$6,640	$5,939
Assets, Current	$393,397	$465,650	$169,307	$248,391
Goodwill	$190,652	$259,759	$209,073	$11,101
Other Assets, Noncurrent	$4,742	$6,016	$6,107	$3,580
Assets	$701,814	$858,929	$502,643	$358,604
Long-term Debt, Excluding Current Maturities	$228,034	$151,178	$151,624	$151,852
Contract with Customer, Liability, Noncurrent	$77	$249	$410	$425
Operating Lease, Liability, Noncurrent	$17,676	$16,291	$14,208	$12,800
Business Combination, Contingent Consideration, Liability, Noncurrent	—	—	$250	$0
Other Liabilities, Noncurrent	$74	$154	$798	$775
Liabilities	$334,895	$493,722	$256,863	$257,777
Accounts Payable, Current	$6,641	$11,433	$9,363	$8,338
Contract with Customer, Liability, Current	$55,753	$53,281	$56,107	$42,534
Operating Lease, Liability, Current	$3,358	$3,614	$3,779	$3,698
Long-term Debt, Current Maturities	—	$231,182	$1,627	$1,627
Liabilities, Current	$89,034	$325,850	$89,573	$91,925
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stocks, Including Additional Paid in Capital	$1,484,056	$1,552,714	$1,608,840	$1,616,004
Retained Earnings (Accumulated Deficit)	$-1,117,170	$-1,186,672	$-1,364,646	$-1,516,209
Accumulated Other Comprehensive Income (Loss), Net of Tax	$33	$-835	$1,586	$1,032
Stockholders' Equity Attributable to Parent	$366,919	$365,207	$245,780	$100,827
Preferred Stock, Shares Authorized	25,000,000	25,000,000	25,000,000	25,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	58,295,491	64,043,799	72,027,332	74,598,492
Operating Lease, Liability	$21,034	$19,905	$17,987	$17,987

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-118,147	$-69,502	$-177,974	$-264,817
Net Cash Provided by (Used in) Operating Activities	$-33,080	$14,559	$731	$28,234
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$21	$-34	$27	$-84
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-10,036	$143,369	$-198,831	$9,877
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$106,276	$249,645	$50,814	$-231,290
Share-based Payment Arrangement, Noncash Expense	$55,756	$40,128	$27,012	$17,625
Proceeds from Sale, Maturity and Collection of Investments	$336,801	$242,067	$163,948	$66,840
Depreciation, Depletion and Amortization, Nonproduction	$42,223	$41,431	$50,500	$48,590
Payments to Acquire Investments	$290,836	$168,307	$65,132	$62,039
Accretion (Amortization) of Discounts and Premiums, Investments	$9,720	$4,757	$1,565	$1,134
Tangible Asset Impairment Charges	—	—	$6,900	$6,900
Payments to Acquire Businesses, Net of Cash Acquired	$11,392	$80,277	$41,114	$0
Payments to Acquire Property, Plant, and Equipment	$1,236	$1,616	$968	$1,211
Financing Receivable, Credit Loss, Expense (Reversal)	$1,821	$1,202	$1,503	$1,441
Payments to Acquire Intangible Assets	$1,118	$508	$805	$1,368
Amortization of Debt Issuance Costs and Discounts	$1,511	$3,256	$3,725	$2,790
Proceeds from Sale of Property, Plant, and Equipment	$31	$13	$44	$34
Deferred Income Tax Expense (Benefit)	$8	$77	$81	$342
Net Cash Provided by (Used in) Investing Activities	$20,293	$-22,902	$36,193	$-16,848
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$0	$-1,642	$-7,063	$-2,145
Goodwill and Intangible Asset Impairment	—	—	$110,223	$110,223
Other Operating Activities, Cash Flow Statement	$67	$141	$-429	$574
Proceeds from Issuance of Long-term Debt	—	—	$0	$0
Payments of Financing Costs	—	$2,152	$0	$0
Repayments of Other Debt	—	—	$232,292	$2,292
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$3,588	$2,411	$1,510	$867
Proceeds from Stock Options Exercised	$950	$169	$0	$0
Payments for Repurchase of Common Stock	$1,808	$0	$5,000	$0
Net Cash Provided by (Used in) Financing Activities	$2,730	$151,746	$-235,782	$-1,425
Interest Paid, Excluding Capitalized Interest, Operating Activities	$5,750	$10,119	$21,949	$21,949
Stock Issued During Period, Value, Acquisitions	$0	$24,932	$31,584	$0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$2,033	$1,267	$806	$-145
Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense	$889	$1,018	$1,020	$805
Capital Expenditures Incurred but Not yet Paid	$7	$13	$76	$79
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$1,310	$0	$1,659	$1,659
Increase (Decrease) in Accounts Receivable	$13,663	$-4,281	$1,809	$-19,532
Increase (Decrease) in Prepaid Expense and Other Assets	$-164	$50	$-1,569	$-2,764
Increase (Decrease) in Contract with Customer, Liability	$-1,487	$-7,012	$607	$-13,098

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("HCAT","financials")

Full statements spill as a table. For one cell: =jivedata("HCAT","Revenue") or =jivedata("HCAT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.